Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
67.041,81
-0,06%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Progenics Pharmaceuticals Inc (PGNX) Progenics Pharmaceuticals Inc (PGNX) Notizie

PGNX

Progenics Pharmaceuticals (PGNX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PGNX
DataOraFonteTitoloSimboloCompagnia
08/02/202218:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
23/06/202022:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202014:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202014:11Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202013:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202013:00Business WireLantheus Completes Merger with ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
17/06/202023:33PR Newswire (US)Independent Bank Group Set to Join S&P SmallCap 600NASDAQ:PGNXProgenics Pharmaceuticals Inc
16/06/202022:05GlobeNewswire Inc.Progenics Stockholders Approve Merger with LantheusNASDAQ:PGNXProgenics Pharmaceuticals Inc
28/05/202001:53PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.NASDAQ:PGNXProgenics Pharmaceuticals Inc
18/05/202014:30GlobeNewswire Inc.Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society ...NASDAQ:PGNXProgenics Pharmaceuticals Inc
14/05/202015:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
12/05/202022:33Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PGNXProgenics Pharmaceuticals Inc
08/05/202023:14PR Newswire (US)Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceutica...NASDAQ:PGNXProgenics Pharmaceuticals Inc
07/05/202022:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PGNXProgenics Pharmaceuticals Inc
07/05/202013:30GlobeNewswire Inc.Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business UpdateNASDAQ:PGNXProgenics Pharmaceuticals Inc
23/04/202023:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PGNXProgenics Pharmaceuticals Inc
23/04/202014:30GlobeNewswire Inc.Progenics Pharmaceuticals Sets First Quarter 2020 Financial Results and Business Update Call for May 7NASDAQ:PGNXProgenics Pharmaceuticals Inc
15/04/202021:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
14/04/202017:17Business WireADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
14/04/202015:00Business WireVelan Capital Agrees to Support Merger of Lantheus and ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
19/03/202014:06Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
13/03/202021:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PGNXProgenics Pharmaceuticals Inc
13/03/202013:30GlobeNewswire Inc.PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTSNASDAQ:PGNXProgenics Pharmaceuticals Inc
20/02/202017:30Business WireLantheus and Progenics Agree to Amended Transaction TermsNASDAQ:PGNXProgenics Pharmaceuticals Inc
14/02/202019:42Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PGNXProgenics Pharmaceuticals Inc
06/02/202014:30GlobeNewswire Inc.Progenics Pharmaceuticals Announces Presentations at the 2020 American Society of Clinical Oncology Genitourinary Cancers Sym...NASDAQ:PGNXProgenics Pharmaceuticals Inc
21/01/202022:15GlobeNewswire Inc.Progenics Pharmaceuticals Provides Update on Reconstituted Board’s Ongoing Strategic ReviewNASDAQ:PGNXProgenics Pharmaceuticals Inc
16/01/202015:10GlobeNewswire Inc.Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter MeetingNASDAQ:PGNXProgenics Pharmaceuticals Inc
23/12/201913:00GlobeNewswire Inc.Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary EndpointNASDAQ:PGNXProgenics Pharmaceuticals Inc
22/12/201923:00GlobeNewswire Inc.Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyL...NASDAQ:PGNXProgenics Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PGNX

La tua Cronologia

TSX
TOCC
TD One Click Conservativ...
COIN
CYCOGBP
COIN
LUAETH
LuaToken
EU
BTGC3
Tagus Soc Titul Creditos...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network